2024 Annual Meeting | H165 - AI on the Hill (Practice and Policy Hub)

Date Tuesday 04/16/24

Time 01:15 PM - 01:45 PM MDT Add To Calendar

Location Colorado Convention Center | Lobby F

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Practice and Policy)

Director(s) James F. Rini, MD, Benjamin R. Kummer, MD, Lidia Maria V. Moura, MD, PhD, MPH, FAAN, Allan D. Wu, MD, FAAN

Topic(s) Practice, Policy, and Ethics

Learning Objectives Participants should be able to critically analyze and differentiate the primary arguments for and against the use of AI in neurology, involving appraising evidence from a multi-disciplinary perspective to understand the full spectrum of benefits and challenges; identify and appraise the current capabilities and limitations of AI technologies in neurology by analyzing real-world case studies and research data, including comparing different AI models, examining their outcomes for patient safety, and discussing the evidence base for their efficacy; interpret and report on various stakeholder perspectives regarding AI in neurology, including those of patients, health care providers, AI developers, and policymakers; evaluate and argue the ethical implications of AI application in neurology by reviewing patient privacy rights, informed consent protocols, and the impact on health care equity; engage in ethical reasoning to assess how AI technology aligns with or conflicts with current ethical standards in health care; examine and compare risk management approaches for using AI in neurology clinics; and learn how to identify possible issues and understand the long-term effects of using AI in health care.

CME Available 0.50 CME credit

Core Competencies Professionalism, Medical Knowledge, Practice-based Learning and Improvement

Program Level Introductory

Program Tracks Artificial Intelligence

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator, Coordinator

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:15 PM - 01:45 PM MDT	Speaker	AI on the Hill James F. Rini, MD, Benjamin R. Kummer, MD, Lidia Maria V. Moura, MD, PhD, MPH, FAAN, Allan D. Wu, MD, FAAN

Faculty Disclosures
James F. Rini, MD	Dr. Rini has a non-compensated relationship as a Member on Advisory Board with Lilly that is relevant to AAN interests or activities.
Benjamin R. Kummer, MD	Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum Partners. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for AlphaSights. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for Gehrson Lehrman Group . Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syapse. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuraHealth. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syntrillo. Dr. Kummer has stock in Syntrillo. The institution of Dr. Kummer has received research support from Icahn School of Medicine at Mount Sinai.
Lidia Maria V. Moura, MD, PhD, MPH, FAAN	Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for eNova. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. The institution of Dr. Moura has received research support from NIH-NIA - 1K08AG053380-01A1. The institution of Dr. Moura has received research support from NIH-NIA 5R01AG062282-02 . The institution of Dr. Moura has received research support from NIH-NIA 2P01AG032952-11 . The institution of Dr. Moura has received research support from NIH- NIA 3R01AG062282-03S1 . The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America .
Allan D. Wu, MD, FAAN	An immediate family member of Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus. An immediate family member of Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biocodex. The institution of Dr. Wu has received research support from Michael J Fox Foundation. The institution of an immediate family member of Dr. Wu has received research support from Amzell. The institution of Dr. Wu has received research support from Centers for Disease Control. Dr. Wu has a non-compensated relationship as a Neuroscience Steering Board with Epic that is relevant to AAN interests or activities.